Evaluation of Treatment Satisfaction in Children With an Allergy and Who Received an Antihistamine

Completed

Conditions studied: Allergies

In brief

This is a non-interventional retrospective data collection study from children aged from 2 to 12 years old diagnosed with an allergy and who received a treatment consisting of an H1-antihistamine. The period of last taken medication will be observed to evaluate the global satisfaction of the parents and physician for this last treatment.

Key facts

Study ID

NCT00453583

Run by

UCB Pharma

People needed

4581

Starts

2007-03-01

Expected to finish

2008-01-01

Last updated by the study team

2013-12-16

Who can join

Age: 2 and older, up to 12. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Children from 2-12 included
• History of allergy
• Used an Antihistamine within market authorization

You may not qualify if…

• Child not yet treated for the presented allergy

Where it is running

• UCB Pharma — Smyrna, Georgia, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.